Company Filing History:
Years Active: 2014-2015
Title: Innovations by Steven Danso: Pioneering Research in Butyrylcholinesterases
Introduction
Steven Danso is an accomplished inventor based in Bonsall, California, with a significant contribution to the field of enzymatic research. He holds two patents that focus on recombinant butyrylcholinesterases, showcasing his expertise in biotechnology and molecular biology.
Latest Patents
Steven's recent patents include breakthroughs related to recombinant butyrylcholinesterases and truncates thereof. These patents disclose isolated nucleic acids encoding polypeptides that exhibit butyrylcholinesterase (BChE) enzyme activity. The inventions outline molecular criteria for preparing such nucleic acids, emphasizing the importance of codon optimization. Additionally, they describe methods for generating modified and/or truncated BChE molecules with specific properties, particularly the selective formation of monomers. Importantly, the patents also cover vectors and cells that contain and/or express these nucleic acids, indicating a robust framework for future research and applications.
Career Highlights
Steven Danso is currently affiliated with Pharmathene, Inc., where he contributes to advancing biopharmaceutical innovations. His work is pivotal in exploring therapeutic applications for enzymes that play a crucial role in various biological processes.
Collaborations
Throughout his career, Steven has worked alongside notable colleagues, including Kalvin Yim and Edward Hausknecht. These collaborations have enriched his research and contributed to the development of ground-breaking solutions in the biotechnological arena.
Conclusion
In summary, Steven Danso's contributions to the field of recombinant butyrylcholinesterases reflect his innovative spirit and dedication to scientific advancement. His patents not only demonstrate his inventiveness but also open avenues for future research and therapeutic applications that could impact medicine and biotechnology significantly.